Table 1 Baseline characteristics of patients on ICU admission Categorical variables are expressed as number (%) and continuous variables as median [interquartile ranges]
Variable | Available/ total (%) | All patients n = 283 |
|---|---|---|
Age (years) | 283/283 (100) | 67 [59;72] |
Sex (male), n (%) | 283/283 (100) | 202 (71) |
Body mass index (kg/m2) | 283/283 (100) | 29.4 [26.0;34.3] |
History of cardiac disease, n (%) | 283/283 (100) | 38 (13) |
History of chronic respiratory disease, n (%) | 283/283 (100) | 9 (3) |
Diabetes mellitus, n (%) | 283/283 (100) | 93 (33) |
Cirrhosis, n (%) | 283/283 (100) | 4 (1) |
Solid organ malignancy, n (%) | 283/283 (100) | 12 (4) |
Hematological malignancy, n (%) | 283/283 (100) | 14 (5) |
Hypertension, n (%) | 283/283 (100) | 159 (56) |
Immunosuppression, n (%) | 283/283 (100) | 43 (18) |
SARS-CoV-2 vaccination, n (%) | 191/283 (67) | 14 (7) |
SOFA score on ICU admission | 283/283 (100) | 4 [3;5] |
SAPS II | 283/283 (100) | 37 [31;43] |
Onset of symptoms to ICU admission (days) | 283/283 (100) | 8 [6;11] |
PaO2/FiO2 on admission (mmHg) | 281/283 (99) | 93 [73;120] |
PaCO2 on admission (mmHg) | 281/283 (99) | 34 [31;38] |
Respiratory rate on admission (cycles/min) | 275/283 (97) | 33 [29;38] |
Use of corticosteroids, n (%) | 283/283 (100) | 183 (65) |
Use of anti-IL6-R, n (%) | 283/283 (100) | 21 (7) |
Modality of oxygenation before invasive mechanical ventilation, n (%) | 283/283 (100) | |
Standard oxygen therapy | 32 (11) | |
High-flow oxygen therapy | 244 (86) | |
Noninvasive ventilation | 7 (3) | |
ICU admission to intubation (days) | 283/283 (100) | 1 [1;3] |